These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 21037280)

  • 41. The process-inducing activity of transmembrane agrin requires follistatin-like domains.
    Porten E; Seliger B; Schneider VA; Wöll S; Stangel D; Ramseger R; Kröger S
    J Biol Chem; 2010 Jan; 285(5):3114-25. PubMed ID: 19940118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural domains of agrin required for clustering of nicotinic acetylcholine receptors.
    Hoch W; Campanelli JT; Harrison S; Scheller RH
    EMBO J; 1994 Jun; 13(12):2814-21. PubMed ID: 8026466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Agrin binds BMP2, BMP4 and TGFbeta1.
    Bányai L; Sonderegger P; Patthy L
    PLoS One; 2010 May; 5(5):e10758. PubMed ID: 20505824
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An affinity-based approach to engineer laminin-presenting cell instructive microenvironments.
    Barros D; Parreira P; Furtado J; Ferreira-da-Silva F; Conde-Sousa E; García AJ; Martins MCL; Amaral IF; Pêgo AP
    Biomaterials; 2019 Feb; 192():601-611. PubMed ID: 30509501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural characterization of the third scavenger receptor cysteine-rich domain of murine neurotrypsin.
    Canciani A; Catucci G; Forneris F
    Protein Sci; 2019 Apr; 28(4):746-755. PubMed ID: 30748049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mouse AChE binds in vivo to domain IV of laminin-1beta.
    Paraoanu LE; Layer PG
    Chem Biol Interact; 2005 Dec; 157-158():411-3. PubMed ID: 16429555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Glycosaminoglycan Side Chains and Modular Core Proteins of Heparan Sulphate Proteoglycans and the Varied Ways They Provide Tissue Protection by Regulating Physiological Processes and Cellular Behaviour.
    Farrugia BL; Melrose J
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762403
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extracellular Matrix of Echinoderms.
    Dolmatov IY; Nizhnichenko VA
    Mar Drugs; 2023 Jul; 21(7):. PubMed ID: 37504948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural mechanisms of the agrin-LRP4-MuSK signaling pathway in neuromuscular junction differentiation.
    Zong Y; Jin R
    Cell Mol Life Sci; 2013 Sep; 70(17):3077-88. PubMed ID: 23178848
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neural agrin: a synaptic stabiliser.
    Ngo ST; Noakes PG; Phillips WD
    Int J Biochem Cell Biol; 2007; 39(5):863-7. PubMed ID: 17126587
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural and biophysical characterisation of agrin laminin G3 domain constructs.
    Tidow H; Mattle D; Nissen P
    Protein Eng Des Sel; 2011 Jan; 24(1-2):219-24. PubMed ID: 21037280
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The laminin-binding domain of agrin is structurally related to N-TIMP-1.
    Stetefeld J; Jenny M; Schulthess T; Landwehr R; Schumacher B; Frank S; Rüegg MA; Engel J; Kammerer RA
    Nat Struct Biol; 2001 Aug; 8(8):705-9. PubMed ID: 11473262
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alpha3Na+/K+-ATPase is a neuronal receptor for agrin.
    Hilgenberg LG; Su H; Gu H; O'Dowd DK; Smith MA
    Cell; 2006 Apr; 125(2):359-69. PubMed ID: 16630822
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mapping of the laminin-binding site of the N-terminal agrin domain (NtA).
    Mascarenhas JB; Rüegg MA; Winzen U; Halfter W; Engel J; Stetefeld J
    EMBO J; 2003 Feb; 22(3):529-36. PubMed ID: 12554653
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electron microscopic structure of agrin and mapping of its binding site in laminin-1.
    Denzer AJ; Schulthess T; Fauser C; Schumacher B; Kammerer RA; Engel J; Ruegg MA
    EMBO J; 1998 Jan; 17(2):335-43. PubMed ID: 9430625
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.